01093 CSPC PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 2.27X | Oper Margin | 19.7% |
|---|---|---|---|
| LT Debt/Equity | 0.2% | Net Margin | 14.9% |
| Total Debt/Equity | 1.6% | Return on Equity | 13.4% |
| Price/Book | 3.89X | Return on Assets | 9.8% |
| (HKD 11.480) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 4,602.87 | 6,473.58 | 6,829.67 | 6,855.70 | 6,123.48 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -28.9 | -5.2 | -0.4 | +12.0 | +47.5 |
| Earnings Per Share (HKD) | 0.392 | 0.545 | 0.573 | 0.574 | 0.512 |
| Earnings Per Share Growth (%) | -28.1 | -4.9 | -0.1 | +12.0 | +47.5 |
| Dividend Per Share (HKD) | 0.260 | 0.280 | 0.210 | 0.180 | 0.128 |
| P/E* (X) | 29.28 | 21.05 | 20.03 | 20.02 | 22.41 |
| Yield (%) | 2.26 | 2.44 | 1.83 | 1.57 | 1.11 |
| Dividend Share (%) | 66.31 | 51.35 | 36.64 | 31.39 | 24.89 |
| Book NAV (HKD) | 2.948 | 3.075 | 2.837 | 2.660 | 2.214 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 13,273 | 16,284 | -18.5 | 16,080 |
| Operating Result | 3,130 | 3,853 | -18.8 | 3,700 |
| Associates | -12.769 | -51.669 | -75.3 | -18.503 |
| Profit Before Taxation | 3,118 | 3,801 | -18.0 | 3,682 |
| Taxation | 543.617 | 749.664 | -27.5 | 623.514 |
| Profit /( Loss) After Taxation | 2,574 | 3,051 | -15.6 | 3,058 |
| Minority Interests | 26.199 | 31.092 | -15.7 | 91.053 |
| Net Profit | 2,548 | 3,020 | -15.6 | 2,967 |
| Earnings Per Share () | 0.2442 | 0.2742 | -10.9 | 0.2692 |
| Dividend Per Share () | 0.1400 | 0.1600 | -12.5 | 0.1400 |
| Announcement Date | 2025-08-22 | 2024-08-21 | NA | 2023-08-23 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
